Increased Bone Turnover in Prepubertal, Pubertal, and Postpubertal Patients Receiving Carbamazepine
- A. Verrotti, R. Greco, G. Latini, G. Morgese, F. Chiarelli
- MedicineEpilepsia
- 1 December 2002
Summary: Purpose: To study the markers of bone turnover in epilepsy patients in the different stages of the pubertal growth before and after the beginning of carbamazepine (CBZ) monotherapy.
Metabolic and endocrine effects of valproic acid chronic treatment
- V. Belcastro, C. D’Egidio, P. Striano, A. Verrotti
- Medicine, PsychologyEpilepsy Research
- 1 November 2013
Increased bone turnover in epileptic patients treated with carbamazepine
- A. Verrotti, R. Greco, G. Morgese, F. Chiarelli
- Medicine, BiologyAnnals of Neurology
- 1 March 2000
It is demonstrated that carbamazepine induces an increase of bone turnover and higher values of markers of bone formation and of bone resorption are found in patients than in controls.
Autonomic Neuropathy in Diabetes Mellitus
- A. Verrotti, G. Prezioso, R. Scattoni, F. Chiarelli
- MedicineFrontiers in Endocrinology
- 1 December 2014
The present review summarizes the latest knowledge regarding clinical presentation, epidemiology, pathogenesis, and management of DAN, with some mention to childhood and adolescent population.
Panayiotopoulos syndrome: a consensus view
- C. Ferrie, R. Caraballo, H. Yoshinaga
- MedicineDevelopmental Medicine & Child Neurology
- 1 March 2006
It is concluded that PS is a common idiopathic, benign seizure disorder of childhood, which should be classified as an autonomic epilepsy, rather than an occipital epilepsy.
Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine
- A. Verrotti, R. Pascarella, D. Trotta, T. Giuva, G. Morgese, F. Chiarelli
- MedicineEpilepsy Research
- 2 October 2000
Benign convulsions associated with mild gastroenteritis: A multicenter clinical study
- A. Verrotti, G. Nanni, F. Chiarelli
- Medicine, PsychologyEpilepsy Research
- 1 February 2011
Typical and atypical rolandic epilepsy in childhood: a follow-up study.
- A. Verrotti, G. Latini, F. Chiarelli
- Psychology, MedicinePediatric Neurology
- 2002
Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications
- A. Verrotti, C. D’Egidio, A. Mohn, G. Coppola, F. Chiarelli
- Medicine, PsychologyObesity Reviews
- 1 May 2011
Investigation of the possible causal link between treatment and weight gain in epileptic patients to investigate the real extent of this side effect of valproic acid and its clinical implications, such as an increased risk of insulin resistance and other secondary metabolic abnormalities.
Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): An open-label, parallel group trial
- G. Coppola, E. Franzoni, A. Pascotto
- Medicine, PsychologyBrain & development (Tokyo. )
- 1 June 2007
...
...